ClassID:

21544

A61K51/0446 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Sub-classes:
Recent Application in this class:
#1
20260048156
2026-02-19

FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS

#2
20260027241
2026-01-29

Near-Infrared Dyes And Conjugates For Targeting Tumors

#3
20250360237
2025-11-27

TARGETING SYSTEM FOR CANCER TREATMENT

#4
20250360233
2025-11-27

Central Neurodegeneration Imaging Agent and Method of Preparing the Same

#5
20250263393
2025-08-21

FAP INHIBITORS

#6
20250215021
2025-07-03

SYSTEMS AND METHODS UTILIZING THERANOSTIC AGENTS FOR BPCT AND BNCT FOR TARGETED CANCER TREATMENT

#7
20250170124
2025-05-29

METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASES

#8
20250152758
2025-05-15

PROBE FOR NUCLEAR MEDICAL TESTING

#9
20250114487
2025-04-10

COMBINATION TREATMENT OF TUMORS

#10
20250057994
2025-02-20

LABELED COMPOUNDS AND CALCIUM SENSING RECEPTOR LIGANDS FOR IMAGING AND USES THEREOF

#11
20250009897
2025-01-09

PHARMACEUTICAL COMPOSITION CONTAINING TAGGED SITE-ANTIHUMAN ANTIBODY FAB FRAGMENT COMPLEX

#12
20240399001
2024-12-05

RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP)

#13
20240393330
2024-11-28

4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF

#14
20240366807
2024-11-07

RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN

#15
20240358866
2024-10-31

NSAID-DERIVED CONJUGATE COMPOUNDS FOR IMAGING

#16
20240307560
2024-09-19

HEPTAMETHINE CARBOCYANINE DYE-DOTA CONJUGATES COMPLEXED WITH LUTETIUM-177, YTTRIUM-90, OR GALLIUM-68, AND THEIR USES FOR IMAGE-GUIDED RADIOTHERAPY

#17
20240207292
2024-06-27

BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS

#18
20240174608
2024-05-30

COMPOUNDS FOR BRAIN IMAGING

#19
20240123095
2024-04-18

CROSSLINKED RADIOPAQUE NETWORKS FOR MEDICAL APPLICATIONS

#20
20240002376
2024-01-04

COMPOSITIONS AND METHODS FOR G-PROTEIN-COUPLED RECEPTOR 44 DETECTION

#21
20230348405
2023-11-02

PSMA-TARGETING COMPOUNDS AND USES THEREOF

#22
20230346987
2023-11-02

STRUCTURAL DESIGN OF A CRANIAL NERVE DEGENERATION CONTRAST AGENT PRECURSORS

#23
20230159762
2023-05-25

NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION

#24
20230150922
2023-05-18

Fluorinated Derivatives of Gabapentin and Methods of Use Thereof

#25
20220409747
2022-12-29

FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES

#26
20220340524
2022-10-27

Myeloperoxidase Imaging Agents

#27
20220305126
2022-09-29

Method for removing acetaldehyde

#28
20220265870
2022-08-25

MULTIVALENT FIBROBLAST-TARGETED AGENTS AND METHODS OF USE

#29
20220259161
2022-08-18

PSMA-targeting compounds and uses thereof

#30
20220178921
2022-06-09

4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF

#31
20220175974
2022-06-09

TARGETING COMPOUNDS FOR CANCERS SELECTED FROM ESOPHAGUS, PHARYNX AND LARYNX, LUNG, BRAIN, AND INTESTINES

#32
20220152230
2022-05-19

DEVICES AND METHODS FOR RADIOPHARMACEUTICAL SYNTHESIS

#33
20220133919
2022-05-05

ONE STEP 64Cu-BaBaSar-RGD2 PRODUCTION METHOD

#34
20220048872
2022-02-17

PSMA targeted fluorescent agents for image guided surgery

#35
20220031855
2022-02-03

Organic Anion Transporting Peptide-Based Cancer Imaging and Therapy

#36
20220001012
2022-01-06

NOVEL COMPOUNDS AND USES OF SAME FOR NEAR-INFRARED CHERENKOV LUMINESCENCE IMAGING AND/OR FOR DEEP TISSUE TREATMENT BY CHERENKOV DYNAMIC PHOTOTHERAPY

#37
20210355233
2021-11-18

Pharmaceutical composition containing tagged site-antihuman antibody fab fragment complex

#38
20200369626
2020-11-26

COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF

#39
20200324000
2020-10-15

PSMA inhibitor derivatives for labelling with 99mTc via HYNIC, a radiopharmaceutical kit, radiopharmaceutical preparations and their use in prostate cancer diagnostics

#40
20200316230
2020-10-08

DEVICES AND METHODS FOR RADIOPHARMACEUTICAL SYNTHESIS

#41
20200237921
2020-07-30

Method for removing acetaldehyde

#42
20200222564
2020-07-16

Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof

#43
20200216402
2020-07-09

PSMA targeted fluorescent agents for image guided surgery

#44
20200179514
2020-06-11

PHTHALOCYANINE PROBES AND USES THEREOF

#45
20200123104
2020-04-23

PHARMACEUTICAL AGENT THAT BINDS THE P2X7 RECEPTOR

#46
20200109124
2020-04-09

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#47
20200108380
2020-04-09

Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

#48
20200049709
2020-02-13

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

#49
20200023085
2020-01-23

Method for labeling radioisotope radiolabeling compound and kit comprising the same for labeling radioisotope

#50
20200010447
2020-01-09

Radiolabeled pharmaceuticals and methods of making and using same

#51
20190367537
2019-12-05

IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS)

#52
20190315689
2019-10-17

Myeloperoxidase imaging agents

#53
20190240359
2019-08-08

One step 64Cu-BaBaSar-RGD2 production method

#54
20190240342
2019-08-08

ORGANIC ANION TRANSPORTING PEPTIDE-BASED CANCER IMAGING AND THERAPY

#55
20190127394
2019-05-02

BODIPY dyes for biological imaging

#56
20190111161
2019-04-18

IODINATED PHENOLIC LIPIDS AND METHODS AND COSOLVENT SYSTEMS FOR IODINATION OF PHENOLIC LIPIDS

#57
20190100654
2019-04-04

NIR to SWIR fluorescent compounds for imaging and detection

#58
20180339048
2018-11-29

Therapeutic and Diagnostic Probes

#59
20180164312
2018-06-14

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

#60
20180162818
2018-06-14

-astatine containing radiotherapeutics for the treatment of cancer

#61
20180009767
2018-01-11

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#62
20170360945
2017-12-21

Organic anion transporting peptide-based cancer imaging and therapy

#63
20170360943
2017-12-21

Method for removing acetaldehyde

#64
20170283384
2017-10-05

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#65
20170239377
2017-08-24

Molecular probes for multimodality imaging and tracking of stem cells

#66
20170224851
2017-08-10

Metal oxide catalyzed radiofluorination

#67
20170189566
2017-07-06

Alpha-synuclein ligands

#68
20170100493
2017-04-13

RECEPTOR IMAGING SYSTEMS AND RELATED METHODS

#69
20170028087
2017-02-02

Use of N-(4-isopropylphenyl)-5-amino-isoindoline

#70
20170015640
2017-01-19

USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS

#71
20170001957
2017-01-05

RADIOIODINATED BIOCONJUGATION REAGENTS

#72
20160222024
2016-08-04

S-ENANTIOMER OF TETRACYCLIC INDOLE DERIVATIVE AS PBR LIGANDS

#73
20160214936
2016-07-28

Carbazole compounds for in vivo imaging

#74
20160168091
2016-06-16

Enantiomeric separation and purification of 2,3,4,9-tetrahydro-1H-carbazole-4-carboxylic acid amide derivatives

#75
20160158388
2016-06-09

Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

#76
20160144060
2016-05-26

Imaging of meningiomas using phenylbenzothiazole, stilbene, or biphenylalkyne derivatives

#77
20150374858
2015-12-31

Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging

#78
20150374819
2015-12-31

Phthalocyanine probes and uses thereof

#79
20150343084
2015-12-03

Therapeutic and diagnostic probes

#80
20150297760
2015-10-22

18F labeled BODIPY dye and its derivatives for PET imaging of heart perfusion and others

#81
20150291647
2015-10-15

Compositions and methods for 18F-fluorodeoxyglycosylamines

#82
20150252061
2015-09-10

Bodipy dyes for biological imaging

#83
20150217005
2015-08-06

Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of Alzheimer's disease

#84
20150217004
2015-08-06

CARBAMATE COMPOUNDS AND METHODS OF USE IN DISEASES OF THE NERVOUS SYSTEM

#85
20150202333
2015-07-23

Labeled molecular imaging agents and methods of use

#86
20150157743
2015-06-11

Dose synthesis card for use with automated biomarker production system

#87
20150125388
2015-05-07

Molecular probes for multimodality imaging and tracking of stem cells

#88
20150104387
2015-04-16

PSMA-targeting compounds and uses thereof

#89
20150056138
2015-02-26

Radiolabeled inhibitors of the amino acid transporters ASCT1 and ASCT2

#90
20150030540
2015-01-29

Imaging agents for detecting neurological dysfunction

#91
20140364615
2014-12-11

Indole derivatives

#92
20140348746
2014-11-27

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

#93
20140328755
2014-11-06

Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders

#94
20140275539
2014-09-18

STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS

#95
20140248213
2014-09-04

Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties

#96
20140179902
2014-06-26

Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof

#97
20140135397
2014-05-15

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

#98
20140134105
2014-05-15

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

#99
20140128408
2014-05-08

HDAC inhibitors and therapeutic methods using the same

#100
20140112869
2014-04-24

Central nervous system labelling composition for intranasal administration and labelling method and screening method using central nervous system labelling composition for intranasal administration

#101
20130266513
2013-10-10

Imaging of meningiomas using phenylbenzothiazole, stilbene, or biphenylalkyne derivatives

#102
20130189185
2013-07-25

Boron-based dual imaging probes, compositions and methods for rapid aqueous F-18 labeling, and imaging methods using same

#103
20130183240
2013-07-18

In vivo imaging method for cancer

#104
20130177501
2013-07-11

In vivo imaging method of mood disorders

#105
20130149239
2013-06-13

5-PYRROLIDINYLSULFONYL-ISATIN DERIVATIVES

#106
20130022549
2013-01-24

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

#107
20130018026
2013-01-17

HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY

#108
20130017163
2013-01-17

HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY

#109
20120321560
2012-12-20

Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease

#110
20120302755
2012-11-29

Imaging agents for detecting neurological dysfunction

#111
20120213702
2012-08-23

NOVEL DIAGNOSTIC AGENTS FOR THE NON-INVASIVE IN VIVO IMAGING OF AMINOPEPTIDASE N (APN/CD13)

#112
20120107239
2012-05-03

Precursor of Molecular Probe for Pancreatic Islet Imaging and Use of the Same

#113
20120039804
2012-02-16

Novel Tricyclic Modulators of Cannabinoid Receptors

#114
20120020884
2012-01-26

Indole derivatives

#115
20120009121
2012-01-12

PSMA-targeting compounds and uses thereof

#116
20110286922
2011-11-24

IMAGING AND RADIOTHERAPY METHODS

#117
20110190618
2011-08-04

Imaging neuroinflammation

#118
20110190492
2011-08-04

DIAGNOSTIC PROBE FOR CONFORMATION DISEASE

#119
20110182810
2011-07-28

Central nervous system labelling composition for intranasal administration and labelling method and screening method using central nervous system labelling composition for intranasal administration

#120
20110070161
2011-03-24

Active enantiomer

#121
20110064658
2011-03-17

RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors

#122
20110044898
2011-02-24

Translocator protein ligands

#123
20110002849
2011-01-06

Therapy selection method

#124
20100298389
2010-11-25

Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders

#125
20100183509
2010-07-22

Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof

#126
20090202435
2009-08-13

Diagnostic compounds for targeting a chemokine receptors

#127
20090185975
2009-07-23

DIAGNOSTIC PROBE FOR CONFORMATION DISEASE

#128
20090180951
2009-07-16

INHIBITORS OF INTEGRIN VLA-4

#129
20090175794
2009-07-09

Inhibitors of carbonic anhydrase IX

#130
20090169475
2009-07-02

RADIOLABELED DERIVATIVES OF POTENT CHYMASE INHIBITORS

#131
20090068105
2009-03-12

Isatin analogues and uses therefor

#132
20090041664
2009-02-12

5-pyrrolidinylsulfonyl isatin derivatives

#133
20090010845
2009-01-08

Polybiotin compounds of magnetic resonance imaging and drug delivery

#134
20090005595
2009-01-01

Gentisic acid for stabilising 123-I radiopharmaceuticals

#135
20090005545
2009-01-01

METHODS FOR PURIFYING RADIOLABELLED COMPOUNDS

#136
20080267879
2008-10-30

Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders

#137
20080193380
2008-08-14

Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy

#138
20080181848
2008-07-31

METHOD TO DETECT DOPAMINE RECEPTORS IN THE FUNCTIONAL D2HIGH STATE

#139
20060275215
2006-12-07

Novel imaging agents

#140
20060166982
2006-07-27

Isotopically labelly indlinone derivatives and process for their preparation

#141
20050260126
2005-11-24

Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein

#142
20050250834
2005-11-10

Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them

#143
20050136008
2005-06-23

Polybiotin compounds for magnetic resonance imaging and drug delivery

#144
20050032789
2005-02-10

Novel compounds useful in pain management

#145
20050014939
2005-01-20

Fused pyrrolecarboxamides: GABA brain receptor ligands